Healthpeak Properties (NYSE:DOC) Rating Reiterated by Mizuho

Healthpeak Properties (NYSE:DOCGet Free Report)‘s stock had its “buy” rating restated by research analysts at Mizuho in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $22.00 price target on the real estate investment trust’s stock. Mizuho’s target price would indicate a potential upside of 22.36% from the company’s current price.

Several other analysts have also recently commented on DOC. Compass Point decreased their target price on Healthpeak Properties from $19.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, January 2nd. Royal Bank of Canada raised their target price on Healthpeak Properties from $21.00 to $22.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Wells Fargo & Company assumed coverage on Healthpeak Properties in a research report on Monday, March 25th. They issued an “equal weight” rating and a $19.00 target price for the company. Bank of America upgraded Healthpeak Properties from an “underperform” rating to a “buy” rating and boosted their target price for the company from $18.00 to $25.00 in a research note on Monday, April 1st. Finally, StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Friday, April 5th. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and an average target price of $18.10.

View Our Latest Analysis on Healthpeak Properties

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $17.98 on Monday. The stock has a market cap of $12.76 billion, a PE ratio of 32.11, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The business has a fifty day simple moving average of $15.97 and a 200-day simple moving average of $13.53. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.00. Healthpeak Properties has a 12 month low of $15.24 and a 12 month high of $22.38.

Hedge Funds Weigh In On Healthpeak Properties

A number of institutional investors have recently modified their holdings of the company. Sunbelt Securities Inc. bought a new stake in Healthpeak Properties during the first quarter valued at about $27,000. Parallel Advisors LLC grew its holdings in Healthpeak Properties by 274.6% in the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after buying an additional 2,985 shares during the last quarter. Benjamin Edwards Inc. grew its holdings in Healthpeak Properties by 99.7% in the 2nd quarter. Benjamin Edwards Inc. now owns 5,237 shares of the real estate investment trust’s stock valued at $73,000 after buying an additional 2,614 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock worth $70,000 after buying an additional 1,712 shares during the period. Finally, Worth Asset Management LLC acquired a new position in shares of Healthpeak Properties during the first quarter worth approximately $102,000. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Recommended Stories

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.